597 related articles for article (PubMed ID: 28584052)
1. Mutations in
Willems AP; Gundogdu M; Kempers MJE; Giltay JC; Pfundt R; Elferink M; Loza BF; Fuijkschot J; Ferenbach AT; van Gassen KLI; van Aalten DMF; Lefeber DJ
J Biol Chem; 2017 Jul; 292(30):12621-12631. PubMed ID: 28584052
[No Abstract] [Full Text] [Related]
2.
Selvan N; George S; Serajee FJ; Shaw M; Hobson L; Kalscheuer V; Prasad N; Levy SE; Taylor J; Aftimos S; Schwartz CE; Huq AM; Gecz J; Wells L
J Biol Chem; 2018 Jul; 293(27):10810-10824. PubMed ID: 29769320
[TBL] [Abstract][Full Text] [Related]
3. A missense mutation in the catalytic domain of O-GlcNAc transferase links perturbations in protein O-GlcNAcylation to X-linked intellectual disability.
Pravata VM; Gundogdu M; Bartual SG; Ferenbach AT; Stavridis M; Õunap K; Pajusalu S; Žordania R; Wojcik MH; van Aalten DMF
FEBS Lett; 2020 Feb; 594(4):717-727. PubMed ID: 31627256
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of a missense mutation in the
Vaidyanathan K; Niranjan T; Selvan N; Teo CF; May M; Patel S; Weatherly B; Skinner C; Opitz J; Carey J; Viskochil D; Gecz J; Shaw M; Peng Y; Alexov E; Wang T; Schwartz C; Wells L
J Biol Chem; 2017 May; 292(21):8948-8963. PubMed ID: 28302723
[No Abstract] [Full Text] [Related]
5. The conserved threonine-rich region of the HCF-1
Kapuria V; Röhrig UF; Waridel P; Lammers F; Borodkin VS; van Aalten DMF; Zoete V; Herr W
J Biol Chem; 2018 Nov; 293(46):17754-17768. PubMed ID: 30224358
[No Abstract] [Full Text] [Related]
6. Neurodevelopmental defects in a mouse model of O-GlcNAc transferase intellectual disability.
Authier F; Ondruskova N; Ferenbach AT; McNeilly AD; van Aalten DMF
Dis Model Mech; 2024 Apr; 17(4):. PubMed ID: 38566589
[TBL] [Abstract][Full Text] [Related]
7. Feedback Regulation of
Lin CH; Liao CC; Chen MY; Chou TY
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33801653
[TBL] [Abstract][Full Text] [Related]
8. Catalytic deficiency of O-GlcNAc transferase leads to X-linked intellectual disability.
Pravata VM; Muha V; Gundogdu M; Ferenbach AT; Kakade PS; Vandadi V; Wilmes AC; Borodkin VS; Joss S; Stavridis MP; van Aalten DMF
Proc Natl Acad Sci U S A; 2019 Jul; 116(30):14961-14970. PubMed ID: 31296563
[TBL] [Abstract][Full Text] [Related]
9. An O-GlcNAc transferase pathogenic variant linked to intellectual disability affects pluripotent stem cell self-renewal.
Omelková M; Fenger CD; Murray M; Hammer TB; Pravata VM; Bartual SG; Czajewski I; Bayat A; Ferenbach AT; Stavridis MP; van Aalten DMF
Dis Model Mech; 2023 Jun; 16(6):. PubMed ID: 37334838
[TBL] [Abstract][Full Text] [Related]
10. The O-GlcNAc Transferase Intellectual Disability Mutation L254F Distorts the TPR Helix.
Gundogdu M; Llabrés S; Gorelik A; Ferenbach AT; Zachariae U; van Aalten DMF
Cell Chem Biol; 2018 May; 25(5):513-518.e4. PubMed ID: 29606577
[TBL] [Abstract][Full Text] [Related]
11. Intellectual disability-associated disruption of O-GlcNAc cycling impairs habituation learning in Drosophila.
Fenckova M; Muha V; Mariappa D; Catinozzi M; Czajewski I; Blok LER; Ferenbach AT; Storkebaum E; Schenck A; van Aalten DMF
PLoS Genet; 2022 May; 18(5):e1010159. PubMed ID: 35500025
[TBL] [Abstract][Full Text] [Related]
12. Changes in O-Linked N-Acetylglucosamine (O-GlcNAc) Homeostasis Activate the p53 Pathway in Ovarian Cancer Cells.
de Queiroz RM; Madan R; Chien J; Dias WB; Slawson C
J Biol Chem; 2016 Sep; 291(36):18897-914. PubMed ID: 27402830
[TBL] [Abstract][Full Text] [Related]
13. Bioinformatic prediction of putative conveyers of O-GlcNAc transferase intellectual disability.
Mitchell CW; Czajewski I; van Aalten DMF
J Biol Chem; 2022 Sep; 298(9):102276. PubMed ID: 35863433
[TBL] [Abstract][Full Text] [Related]
14. Generation of an Interactome for the Tetratricopeptide Repeat Domain of O-GlcNAc Transferase Indicates a Role for the Enzyme in Intellectual Disability.
Stephen HM; Praissman JL; Wells L
J Proteome Res; 2021 Feb; 20(2):1229-1242. PubMed ID: 33356293
[TBL] [Abstract][Full Text] [Related]
15. Elucidating the protein substrate recognition of O-GlcNAc transferase (OGT) toward O-GlcNAcase (OGA) using a GlcNAc electrophilic probe.
Kositzke A; Fan D; Wang A; Li H; Worth M; Jiang J
Int J Biol Macromol; 2021 Feb; 169():51-59. PubMed ID: 33333092
[TBL] [Abstract][Full Text] [Related]
16. An intellectual disability syndrome with single-nucleotide variants in O-GlcNAc transferase.
Pravata VM; Omelková M; Stavridis MP; Desbiens CM; Stephen HM; Lefeber DJ; Gecz J; Gundogdu M; Õunap K; Joss S; Schwartz CE; Wells L; van Aalten DMF
Eur J Hum Genet; 2020 Jun; 28(6):706-714. PubMed ID: 32080367
[TBL] [Abstract][Full Text] [Related]
17. Undetectable histone O-GlcNAcylation in mammalian cells.
Gagnon J; Daou S; Zamorano N; Iannantuono NV; Hammond-Martel I; Mashtalir N; Bonneil E; Wurtele H; Thibault P; Affar el B
Epigenetics; 2015; 10(8):677-91. PubMed ID: 26075789
[TBL] [Abstract][Full Text] [Related]
18. Engineering a Proximity-Directed O-GlcNAc Transferase for Selective Protein O-GlcNAcylation in Cells.
Ramirez DH; Aonbangkhen C; Wu HY; Naftaly JA; Tang S; O'Meara TR; Woo CM
ACS Chem Biol; 2020 Apr; 15(4):1059-1066. PubMed ID: 32119511
[TBL] [Abstract][Full Text] [Related]
19. Enhanced transfer of a photocross-linking N-acetylglucosamine (GlcNAc) analog by an O-GlcNAc transferase mutant with converted substrate specificity.
Rodriguez AC; Yu SH; Li B; Zegzouti H; Kohler JJ
J Biol Chem; 2015 Sep; 290(37):22638-48. PubMed ID: 26240142
[TBL] [Abstract][Full Text] [Related]
20. The O-GlcNAc cycling in neurodevelopment and associated diseases.
Wenzel DM; Olivier-Van Stichelen S
Biochem Soc Trans; 2022 Dec; 50(6):1693-1702. PubMed ID: 36383066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
